Sarcomatoid renal cell carcinoma: Biology and treatment advances

被引：48
|
作者：
El Mouallem, Nemer [1 ]
Smith, Steven C. [2 ]
Paul, Asit K. [1 ]
机构：
[1] Virginia Commonwealth Univ, Div Hematol Oncol & Palliat Care, Massey Canc Ctr, VCU Med Ctr, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Dept Pathol, Massey Canc Ctr, VCU Med Ctr, Richmond, VA USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2018年 / 36卷 / 06期
关键词：
Sarcomatoid renal cell carcinoma; Renal cell carcinoma; Nephrectomy; Chemotherapy; Targeted therapy; Immunotherapy; CYTOREDUCTIVE NEPHRECTOMY; INTERNATIONAL SOCIETY; ANTI-PD-L1; ANTIBODY; PD-L1; EXPRESSION; CANCER; TUMORS; CLASSIFICATION; PATHOLOGY; BIOPSY; SAFETY;
D O I：
10.1016/j.urolonc.2017.12.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sarcomatoid transformation in renal cell carcinoma, so called sacromatoid RCC (sRCC), is associated with an aggressive behavior and a poor prognosis. Current therapeutic approaches are largely ineffective. Recent studies looking into the genomic and molecular characterization of sRCCs have provided insights into the biology and pathogenesis of this entity. These advances in molecular signatures may help development of effective treatment strategies. We herein present a review of recent developments in the pathology, biology, and treatment modalities in sRCC. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码：265 / 271
页数：7
相关论文
共 50 条
  • [21] Biomarker Expression in Sarcomatoid Renal Cell Carcinoma: Comparison with Non-Sarcomatoid Components, and Renal Cell Carcinoma Unclassified
    Liu, L.
    Yin-Goen, Q.
    Young, A. N.
    Osunkoya, A. O.
    LABORATORY INVESTIGATION, 2011, 91 : 208A - 208A
  • [22] Biomarker Expression in Sarcomatoid Renal Cell Carcinoma: Comparison with Non-Sarcomatoid Components, and Renal Cell Carcinoma Unclassified
    Liu, L.
    Yin-Goen, Q.
    Young, A. N.
    Osunkoya, A. O.
    MODERN PATHOLOGY, 2011, 24 : 208A - 208A
  • [23] The Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation
    Resim, Sefa
    Bakaris, Sevgi
    Citil, Rana
    Efe, Erkan
    Benlioglu, Can
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2014, 11 : 14 - 17
  • [24] Sarcomatoid renal cell carcinoma: The chromophobe connection
    Akhtar, M
    Tulbah, A
    Kardar, AH
    Ali, MA
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (10) : 1188 - 1195
  • [25] Immunohistochemistical Profile of Sarcomatoid Renal Cell Carcinoma
    Chang, A.
    Montgomery, E.
    Epstein, J. I.
    LABORATORY INVESTIGATION, 2010, 90 : 183A - 183A
  • [26] Survival outcomes in sarcomatoid renal cell carcinoma
    Al-Juhaishi, Taha
    Alder, Laura
    Paul, Asit K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Systemic therapy for sarcomatoid renal cell carcinoma
    Pagliaro, Lance C.
    Tannir, Nizar
    Sircar, Kanishka
    Jonasch, Eric
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (06) : 913 - 920
  • [28] Sarcomatoid and Rhabdoid Differentiation in Renal Cell Carcinoma
    Zein-Sabatto, Bassel
    Ceballos, Brian
    Canete-Portillo, Sofia
    Rais-Bahrami, Soroush
    Magi-Galluzzi, Cristina
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 707 - 708
  • [29] Sarcomatoid and Rhabdoid Differentiation in Renal Cell Carcinoma
    Zein-Sabatto, Bassel
    Ceballos, Brian
    Canete-Portillo, Sofia
    Rais-Bahrami, Soroush
    Magi-Galluzzi, Cristina
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 707 - 708
  • [30] Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation
    Lichtbroun, Benjamin J.
    Shinder, Brian
    Sara, Tina Gowda
    Srivastava, Arnav
    Saraiya, Biren
    Mayer, Tina M.
    Cristelli, Ryan
    Sadimin, Evita
    Weiss, Robert E.
    Singer, Eric A.
    JOURNAL OF KIDNEY CANCER AND VHL, 2023, 10 (03): : 1 - 8
12345